---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-26-000196"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2026-08-05T20:07:40+00:00"
generated_at: "2026-08-05T20:10:22.322917+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Clover Health Q2 2026 GAAP net income $28M, revenue up 56% YoY, raises full-year guidance

## Summary
- Q2 GAAP net income $28M vs loss $10.6M YoY; revenue $743M (+56%).
- Medicare Advantage membership 157,309 (+48% YoY); Insurance BER 87.6% (improved 80 bps).
- Adjusted EBITDA $40.9M (+139% YoY); Adjusted net income $40.4M.
- Raised FY 2026 guidance: revenue $2.92B-$3.00B, GAAP net income $20M-$35M, Adjusted EBITDA $70M-$85M.
- CEO cites AI-powered Clover Assistant platform driving growth and profitability.

## SEC filing metadata
- accession: 0001801170-26-000196
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2026-08-05T20:07:40+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/0001801170-26-000196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/clov-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-26-000196
- JSON: https://secwatch.observer/filing/0001801170-26-000196.json
- Plain text: https://secwatch.observer/filing/0001801170-26-000196.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.